A Survey Evaluating Consumers Knowledge, Perception, Awareness and Preparedness about Generic Medicines in Urban Central Gujarat Region

Authors(2) :-Kishnani T K, Patel Vipul P.

The questionnaire based survey study was conducted to understand the perception about the generic medicines in consumer's mind of urban Madhya Gujarat region precisely Vadodara, Dahod and Godhra. It was a questionnaire based survey intended to understand exactly what consumers’ think about generic medicines i.e. quality, awareness and preparedness etc. The results of the study show that the consumers were not so clear and confident about these aspects regarding generic medicines but nearly all were facing the issue of costly medicines. When asked about the government’s latest initiatives like Jan Aushadhi Kendra and Din Dayal Upadhyay pharmacy many were aware about it. Many consumers had heard or read about such stores on TV, Radio and newspapers. Most were happy with such efforts of government and were interested in availing benefits of cheaper medicines. Many were unclear about availing such benefit due to their previous experience which points at the ongoing situation where doctors prescribe medicines which are only available in store in doctor’s hospital premises or nearby medical store. It was the prime concerned and not the quality and efficacy of generic medicines. It was found that consumers were very aware about cosmetics. Something must be done to make the consumers’ more aware and doctors more encouraged about generic medicines. Most of the consumers echoed in one voice that more such stores and efforts are needed.

Authors and Affiliations

Kishnani T K
Pharmacy, Hemchandracharya North Gujarat University, Patan, Gujarat, India
Patel Vipul P.
Department of Quality Assurance, Sanjivani College of Pharmaceutical Education and Research, Kopargaon, Maharashtra, India

Questionnaire, Generic Medicines, Consumers, Vadodara, Godhra, Dahod

  1. World Health Organization (WHO). Generic drugs. Geneva: WHO;2015.http://www.who.int/trade/glossary/story034/en/index.html.
  2. US Food and Drug Administration (FDA). pproval of generic drugs. In: Generic drugs. Silver Spring, MD:FDA;2008.http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/SmallusinessAssistance/ucm127615.pdf.
  3. European Medicines Agency (EMA). Questions and answers on generic medicines. Canary Wharf: EMA;2011.http://www.ema.europa.eu/docs/en_GB/document_library/Medicine_QA/2009/11/WC500012382.pdf
  4. Organization for Economic Co-operation and Development (OECD). What future for health spending? OECD Economics Department Policy Notes.2013;19:113.http://www.oecd.org/economy/health-spending.pdf.
  5. World Health Organization (WHO). WHO drug information. Volume 28, No 1. Geneva: WHO; 2014. http://www.who.int/medicines/publications/druginformation/issues/DrugInformation2014_Vol 8 1/en/.
  6. Woerkom M, Piepenbrink H, Godman B, Metz J, Campbell S, Bennie M, et al. Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications
  7. Cameron A, Laing R. Cost savings of switching private sector consumption from originator brand medicines to generic equivalents. Geneva:WHO;2010.http://www.who.int/healthsystems/topics/financing/healthreport/35MedicineCostSavings.pdf.
  8. Godman B, Malmstrom RE, Diogene E, Gray A, Jayathissa S, Timoney A, et al. Are new models needed to optimize the utilization of new medicines to sustain healthcare systems? Expert Rev Clin Pharmacol. 2015;8:7794.
  9. Shrank WH, Cox ER, Fischer MA, Mehta J, Choudhry NK. Patients’ perceptions of generic medications. Health Aff (Millwood). 2009;28:546–56.
  10. Ngo SN, Stupans I, McKinnon RA. Generic substitution in the treatment of epilepsy: patient attitudes and perceptions. Epilepsy Behav. 2013;26:64–6.
  11. Dunne S, Shannon B, Dunne C, Cullen W. Patient perceptions of generic medicines: A mixed-methods study. Patient. 2014;7:177–85. doi:10.1007/ s40271-013-0042-z.
  12. Heikkila R, Mantyselka P, Ahonen R. Do people regard cheaper medicines effective? Population survey on public opinion of generic substitution in Finland. Pharmacoepidemiol Drug Saf. 2011;20:185
  13. Mandates drug stores to display price list, http://setopati.net/ society/7580/ (accessed 30 September 2015).
  14. Kanavos P. Do generics offer significant savings to the UK National Health Service? Curr Med Res Opin 2007; 23(1): 105–116
  15. The World Health Organization: WHO Expert committee on Specifications for Pharmaceutical Preparation Forty-eighth report. WHO Technical Report Series 986. 2014.
  16. Hassali MA, Kong DCM and Stewart K. Knowledge and perceptions of recent pharmacy graduates about generic medicines. Pharm Educ 2007; 7(1): 89–95.
  17. Ministry of Health and Population (MoHP) in collaboration with WHO: Nepal Pharmaceutical Country Profile. 27 September 2011, http://apps.who.int/medicinedocs/en/m/ abstract/Js19096en/ (accessed 15 December 2015).
  18. Decision to fix retail price of drugs challenged in apex court, http://myrepublica.com/politics/story/26621/decision-to-fixretail-price-of-drugs challenged-in-apex-court.html (accessed 30 September 2015)
  19. Ethical criteria for medicinal drug promotion. World Health Organization, 1988,http://apps.who.int/medicinedocs/documents/whozip08e/whozip08e.pdf (accessed 15 December 2015).
  20. Mandates drug stores to display price list, http://setopati.net/ society/7580/ (accessed 30 September 2015).
  21. The World Health Organization: WHO Expert committee on Specifications for Pharmaceutical Preparation Forty-eighth report. WHO Technical Report Series 986. 2014.
  22. School of Medical Sciences. Bachelor of medicine & bachelor of surgery (MBBS) (Curriculum: revised version). Dhulikhel, Nepal: Kathmandu University, 2011.
  23. Hassali MA, Alrasheedy AA, Mclachlan A, et al. The experiences of implementing generic medicine policy in eight countries: a review and recommendations for a successful promotion of generic medicine use. Saudi Pharmaceut J 2014; 22: 491–503.
  24. Facts about Generic Drugs. US Food and Drug Administration,http://www.fda.gov/Drugs/Resources Fo You/Consumers/ Buying Using Medicin Safely/ Understanding GenericDrugs/
  25. Dylst P, Vulto A, Simoens S. Overcoming challenges in market access of generic medicines in the European Union. J Generic Med. 2012;9(21):21 28.
  26. Kjoenniksen I, Lindbaek M, Granas AG. Patients’ attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci. 2006;28(5):284-89.
  27. Mason J. B., Bearden W. O. (1980). Generic drugs: Consumer, pharmacist and physician perceptions of the issues. J. Consum. Aff. 14(1), 193–206
  28. Carroll N. V., Wolfgang A. P. (1989). Inherent risk and market acceptance of generic drug product. J. Health Care Market. 9(4), 48
  29. Babar ZU, Stewart J, Reddy S, Alzaher W, Vareed P, Yacoub N, et al. An evaluation of consumers’ knowledge, perceptions and attitudes regarding generic medicines In Auckland. Pharm World Sci. 2010;32(4):440-8.
  30. Blatt CR, Trauthman SC, Schmidt EH, Marchesan S, Da Silva LM, Martins JL. [General awareness and use of generic medication among citizens of Tubarão, state of Santa Catarina, Brazil]. Cien Saude Colet. 2012;17(1):79-87. Portuguese.
  31. Himmel W, Simmenroth-Nayda A, Niebling W, Ledig T, Jansen RD, Kochen MM, et al. What do primary care patients think about generic drugs? Int J Clin Pharmacol Ther. 2005;43(10):472-9.
  32. Thomas R, Vitry A. Consumers’ perception of generic medicines in community pharmacies in Malaysia. South Med Rev. 2009;2(2):20-3.
  33. Dighe SV. A review of the safety of generic drugs. Transplant Proc. 1999;31(3A Suppl):23S-24S.
  34. World Health Organization (WHO). The World Medicines Situation Report [Internet]. WHO. 2011 [cited 2014 Jul 24]. Available from: http://www.who. int/medicines/areas/policy/world_medicines_situation/wms_intro/en/index.html
  35. World Health Organization (WHO). Health Action International. Measuring medicine prices, availability, affordability and price components [Internet]. WHO. 2008 [cited 2014 Jul 27]. Available from: http://www.who.int/medicines/areas/access/medicines_prices08/en/
  36. Perira JA, Holbrook AM, Dolovich L, Goldsmith C, Thabane L, Douketis JD, et al. Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians. Can J Clin Pharmacol. 2005;12:e229–39.
  37. Sharrad AK, Hassali MA. Consumer perception on generic medicines in Basrah, Iraq: preliminary findings from a qualitative study. Res Social Adm Pharm. 2011;7:108–12. doi:10.1016/j.sapharm.2009.12.003

Publication Details

Published in : Volume 3 | Issue 3 | May-June 2017
Date of Publication : 2017-06-30
License:  This work is licensed under a Creative Commons Attribution 4.0 International License.
Page(s) : 470-475
Manuscript Number : IJSRSET1733110
Publisher : Technoscience Academy

Print ISSN : 2395-1990, Online ISSN : 2394-4099

Cite This Article :

Kishnani T K, Patel Vipul P., " A Survey Evaluating Consumers Knowledge, Perception, Awareness and Preparedness about Generic Medicines in Urban Central Gujarat Region, International Journal of Scientific Research in Science, Engineering and Technology(IJSRSET), Print ISSN : 2395-1990, Online ISSN : 2394-4099, Volume 3, Issue 3, pp.470-475, May-June-2017.
Journal URL : http://ijsrset.com/IJSRSET1733110

Article Preview

Follow Us

Contact Us